| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,223 |
3,955 |
$249K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,311 |
3,241 |
$185K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,146 |
1,059 |
$58K |
| 87428 |
|
929 |
876 |
$40K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,336 |
1,267 |
$36K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
511 |
489 |
$22K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
289 |
285 |
$20K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
651 |
612 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,445 |
1,401 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
438 |
413 |
$3K |
| 99215 |
Prolong outpt/office vis |
25 |
24 |
$2K |
| 99385 |
|
14 |
14 |
$998.40 |
| 81002 |
|
609 |
591 |
$912.20 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
16 |
16 |
$519.74 |
| 99441 |
|
24 |
24 |
$232.28 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
129 |
125 |
$9.15 |